27.600
−0,18%
2026-10-19
Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +30.7% | +14.4% | 2 / 3 | +62.8% | -4.04 pp | -2.10 pp | +14.5% | 1.31 | 8.11 | 1.859 | +62,8% | 131 | +25,5% | 8.11 | 12.25 | −33,8% |
| Pts | 8 | 0 | 8 | 12 | 0 | 0 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 27.600 (close price on 2026-10-19)EPS (TTM): 3.405
Financial charts
1.Revenue & growth
VND bn1.859Q2/26
1.Revenue & growth
VND bn1.859Q2/26
2.Profit & growth
VND bn111Q2/26
3.Profit mix (Penman)
VND bn526Q2/26
4.Margins & cost structure
%13.5%Q2/26
5.Returns & cash cycle
% · days9.0%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn9.719Q2/26
8.Funding & debt health
VND bn · times9.719Q2/26
9.Revenue backlog
VND bn709Q2/26
10.Valuation
times · %8,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %935Q2/26
Adjusted EPS growth, latest quarter
30.7%
Average adjusted EPS growth, 3 quarters
14.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
17.6%
Source: vnstockData through Q2/26